|
Volumn 501, Issue 1-3, 2004, Pages 19-23
|
Antitumor effect of avermectins
|
Author keywords
(Mouse); Avermectin; Tumor growth
|
Indexed keywords
ABAMECTIN;
ANTINEOPLASTIC AGENT;
AVERMECTIN DERIVATIVE;
AVERSECTIN C;
UNCLASSIFIED DRUG;
VINCRISTINE;
ANIMAL EXPERIMENT;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ASCITES;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG EFFECT;
EHRLICH ASCITES TUMOR;
LYMPHATIC LEUKEMIA;
MALE;
MELANOMA;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
STATISTICAL SIGNIFICANCE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, EHRLICH TUMOR;
CELL PROLIFERATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
IVERMECTIN;
LEUKEMIA P388;
MALE;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
MICE, INBRED DBA;
|
EID: 4644238831
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejphar.2004.08.009 Document Type: Article |
Times cited : (45)
|
References (4)
|